Study finds severe COVID-19 in mice induces anti-cancer cells that shrink tumors.

A new study in the Journal of Clinical Investigation shows that severe COVID-19 infections in mice can induce a special type of white blood cell with anti-cancer properties, leading to tumor shrinkage. These induced monocytes target both the virus and cancer cells, offering a new approach to cancer treatment that doesn't depend on T cells. While promising, the research was conducted in mice, so human trials are needed to confirm these findings.

November 22, 2024
12 Articles